MedPath
FDA Approval

Deferasirox

December 30, 2020

HUMAN PRESCRIPTION DRUG LABEL

Deferasirox(500 mg in 1 1)

Manufacturing Establishments (1)

MSN LABORATORIES PRIVATE LIMITED

Dr. Reddy's Laboratories Inc

650786952

Products (3)

Deferasirox

43598-854

ANDA209878

ANDA (C73584)

ORAL

December 30, 2020

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
Code: V8G4MOF2V9Class: ACTIBQuantity: 500 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Deferasirox

43598-856

ANDA209878

ANDA (C73584)

ORAL

December 30, 2020

Code: V8G4MOF2V9Class: ACTIBQuantity: 250 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Deferasirox

43598-855

ANDA209878

ANDA (C73584)

ORAL

December 30, 2020

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4Class: IACT
Code: V8G4MOF2V9Class: ACTIBQuantity: 125 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath